about
Activity of Simulated Human Dosage Regimens of Meropenem and Vaborbactam against Carbapenem-Resistant Enterobacteriaceae in an In Vitro Hollow-Fiber Model.Activity of Meropenem-Vaborbactam in Mouse Models of Infection Due to KPC-Producing Carbapenem-Resistant Enterobacteriaceae.Activity of Meropenem-Vaborbactam against Carbapenem-Resistant Enterobacteriaceae in a Murine Model of Pyelonephritis.Activity of Meropenem-Vaborbactam Against and in a Neutropenic Mouse Thigh Infection ModelPharmacokinetics/Pharmacodynamics of Vaborbactam, a Novel Beta-lactamase Inhibitor, in Combination with Meropenem
P50
description
researcher
@en
name
Mojgan Sabet
@en
type
label
Mojgan Sabet
@en
prefLabel
Mojgan Sabet
@en
P31
P496
0000-0002-5417-0262